HeraMED (ASX:HMD) Interest Expense : A$-0.05 Mil (TTM As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is HeraMED Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. HeraMED's interest expense for the six months ended in Dec. 2024 was A$ 0.01 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.05 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. HeraMED's Operating Income for the six months ended in Dec. 2024 was A$ -2.23 Mil. HeraMED's Interest Expense for the six months ended in Dec. 2024 was A$ 0.01 Mil. HeraMED did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

HeraMED Interest Expense Historical Data

The historical data trend for HeraMED's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeraMED Interest Expense Chart

HeraMED Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-0.01

-2.31

-2.56

-0.13

-0.05

HeraMED Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Interest Expense	Get a 7-Day Free Trial								-0.40	-0.01	-0.13	-0.06	0.01

HeraMED Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.05 Mil.

HeraMED (ASX:HMD) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

HeraMED's Interest Expense for the six months ended in Dec. 2024 was A$0.01 Mil. Its Operating Income for the six months ended in Dec. 2024 was A$-2.23 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2024 was A$0.66 Mil.

HeraMED's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

The higher the ratio, the stronger the company's financial strength is.

HeraMED Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HeraMED Ltd (ASX:HMD) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

201, 697 Burke Road, Suite 4, Camberwell, VIC, AUS, 3124

Website

https://www.hera-med.com

HeraMED Ltd is engaged in developing, connected pregnancy monitoring solutions for home and professional use. It has developed a foetal heartbeat monitor called HeraBEAT which is a medical-grade, clinically-validated, smart and connected Ultrasound Foetal Doppler device predominantly for use by an expectant mother to self-monitor her foetus' heart rate (FHR). It is also focused on the commercialization and deployment of its HeraCARE pregnancy monitoring solution. Geographically, the company generates a majority of its revenue from the United States of America followed by Australia and Israel.

HeraMED Headlines

No Headlines